Comparing the effects of vitamin E tocotrienol-rich fraction supplementation and α-tocopherol supplementation on gene expression in healthy older adults

This study aims to compare the differential gene expression resulting from tocotrienol-rich fraction and α-tocopherol supplementation in healthy older adults. A total of 71 eligible subjects aged 50 to 55 years from Gombak and Kuala Lumpur, Malaysia, were divided into three groups and supplemented w...

Full description

Saved in:
Bibliographic Details
Published inClinics (São Paulo, Brazil) Vol. 74; p. e688
Main Authors Ghani, Siti Madiani Abdul, Goon, Jo Aan, Azman, Nor Helwa Ezzah Nor, Zakaria, Siti Nor Asyikin, Hamid, Zalina, Ngah, Wan Zurinah Wan
Format Journal Article
LanguageEnglish
Published Brazil Elsevier España, S.L.U 01.01.2019
Faculdade de Medicina / USP
Elsevier España
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This study aims to compare the differential gene expression resulting from tocotrienol-rich fraction and α-tocopherol supplementation in healthy older adults. A total of 71 eligible subjects aged 50 to 55 years from Gombak and Kuala Lumpur, Malaysia, were divided into three groups and supplemented with placebo (n=23), α-tocopherol (n=24) or tocotrienol-rich fraction (n=24). Blood samples were collected at baseline and at 3 and 6 months of supplementation for microarray analysis. The number of genes altered by α-tocopherol was higher after 6 months (1,410) than after 3 months (273) of supplementation. α-Tocopherol altered the expression of more genes in males (952) than in females (731). Similarly, tocotrienol-rich fraction modulated the expression of more genes after 6 months (1,084) than after 3 months (596) and affected more genes in males (899) than in females (781). α-Tocopherol supplementation modulated pathways involving the response to stress and stimuli, the immune response, the response to hypoxia and bacteria, the metabolism of toxins and xenobiotics, mitosis, and synaptic transmission as well as activated the mitogen-activated protein kinase and complement pathways after 6 months. However, tocotrienol-rich fraction supplementation affected pathways such as the signal transduction, apoptosis, nuclear factor kappa B kinase, cascade extracellular signal-regulated kinase-1 and extracellular signal-regulated kinase-2, immune response, response to drug, cell adhesion, multicellular organismal development and G protein signaling pathways. Supplementation with either α-tocopherol or tocotrienol-rich fraction affected the immune and drug response and the cell adhesion and signal transduction pathways but modulated other pathways differently after 6 months of supplementation, with sex-specific responses.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
AUTHOR CONTRIBUTIONS
No potential conflict of interest was reported.
Abdul Ghani SM conducted the study, analysis and interpretation of data in addition to drafting the manuscript. Goon JA contributed to the study design and content of the manuscript. Nor Azman NHE and Zakaria SNA were involved in the subject screening, assessment of the physical activity questionnaire and interpretation of the data. Hamid Z contributed to supplying the placebo, α-TF and TRF supplementation capsules. Wan Ngah WZ was instrumental in the study’s inception, design and approval and also provided a critical analysis of the data interpretation and manuscript review. The final manuscript has been read and approved by all authors.
ISSN:1807-5932
1980-5322
1980-5322
DOI:10.6061/clinics/2019/e688